IL128724A - Pharmaceutical compositions containing isovaleric acid derivatives for treating various neurological pathologies - Google Patents

Pharmaceutical compositions containing isovaleric acid derivatives for treating various neurological pathologies

Info

Publication number
IL128724A
IL128724A IL12872497A IL12872497A IL128724A IL 128724 A IL128724 A IL 128724A IL 12872497 A IL12872497 A IL 12872497A IL 12872497 A IL12872497 A IL 12872497A IL 128724 A IL128724 A IL 128724A
Authority
IL
Israel
Prior art keywords
isovaleric acid
pharmaceutical compositions
compositions containing
acid derivatives
treating various
Prior art date
Application number
IL12872497A
Other languages
English (en)
Other versions
IL128724A0 (en
Original Assignee
Nps Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nps Pharma Inc filed Critical Nps Pharma Inc
Priority to IL14547397A priority Critical patent/IL145473A0/xx
Publication of IL128724A0 publication Critical patent/IL128724A0/xx
Publication of IL128724A publication Critical patent/IL128724A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/84Valerianaceae (Valerian family), e.g. valerian
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Psychology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cephalosporin Compounds (AREA)
IL12872497A 1996-08-30 1997-08-29 Pharmaceutical compositions containing isovaleric acid derivatives for treating various neurological pathologies IL128724A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL14547397A IL145473A0 (en) 1996-08-30 1997-08-29 Use of an extract which is a predrug of isovaleric acid for preparing a pharmaceutical composition for treating spasticity and convulsions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2505096P 1996-08-30 1996-08-30
PCT/US1997/015272 WO1998008498A1 (en) 1996-08-30 1997-08-29 Treatment of spasticity, convulsions by isovaleric acid derivatives cns depressants

Publications (2)

Publication Number Publication Date
IL128724A0 IL128724A0 (en) 2000-01-31
IL128724A true IL128724A (en) 2003-05-29

Family

ID=21823778

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12872497A IL128724A (en) 1996-08-30 1997-08-29 Pharmaceutical compositions containing isovaleric acid derivatives for treating various neurological pathologies

Country Status (16)

Country Link
EP (1) EP0938304B1 (ja)
JP (1) JP2000504035A (ja)
KR (1) KR100594400B1 (ja)
CN (2) CN1152677C (ja)
AT (1) ATE284683T1 (ja)
AU (1) AU728765B2 (ja)
BR (1) BR9713188A (ja)
CA (1) CA2264577A1 (ja)
DE (1) DE69731968T2 (ja)
DK (1) DK0938304T3 (ja)
ES (1) ES2235251T3 (ja)
HK (1) HK1023725A1 (ja)
IL (1) IL128724A (ja)
PT (1) PT938304E (ja)
RU (1) RU2232016C2 (ja)
WO (1) WO1998008498A1 (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6589994B1 (en) * 1996-08-30 2003-07-08 Nps Pharmaceuticals, Inc. Treating a variety of pathological conditions, including spasticity and convulsions, by effecting a modulation of CNS activity with isovaleramide, isovaleric acid, or a related compound
EP1059930B1 (en) * 1998-03-04 2005-05-11 Nps Pharmaceuticals, Inc. Compositions comprising isovaleramide and ibuprofen
AU2003204485B2 (en) * 1998-03-04 2006-06-08 Nps Pharmaceuticals, Inc. Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a nsaid
EP1576962A1 (en) * 1998-03-04 2005-09-21 Nps Pharmaceuticals, Inc. Composition comprising isovaleramide and ibuprofen
US6383527B1 (en) * 1999-03-04 2002-05-07 Nps Pharmaceuticals, Inc. Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a NSAID
US6346283B1 (en) * 1999-03-26 2002-02-12 Ancile Pharmaceuticals Use of valeriana for the treatment of restless leg syndrome and related disorders
EP1225888A2 (en) * 1999-10-19 2002-07-31 Nps Pharmaceuticals, Inc. Sustained-release formulations for treating cns-mediated disorders
US7235258B1 (en) 1999-10-19 2007-06-26 Nps Pharmaceuticals, Inc. Sustained-release formulations for treating CNS-mediated disorders
SI1311256T1 (sl) * 2000-08-17 2005-12-31 Teva Pharma Uporaba derivatov amidov valprojske kisline in amidov 2-valproenske kisline za zdravljenje ali preprecevanje bolecin in/ali glavobolnih motenj
EP1385520A4 (en) * 2001-02-08 2007-03-21 Nps Pharma Inc METHODS AND COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRICAL DISEASES AND FOR THE IDENTIFICATION OF COMPOUNDS FOR THE TREATMENT THEREOF
WO2003063605A1 (en) * 2002-02-01 2003-08-07 Eugene Science Inc. Chewing gum composition containing plant sterol for decrease of flood cholesterol levels and prevention of periodontal disease
WO2006012603A2 (en) * 2004-07-22 2006-02-02 Nps Pharmaceuticals, Inc. Analogs of isovaleramide, a pharmaceutical composition including the same, and a method of treating central nervous system conditions or diseases
DE102006062264A1 (de) * 2006-12-22 2008-06-26 Joh. Barth & Sohn Gmbh & Co. Kg Verwendung von Xanthohumol zur Vorbeugung und/oder Bekämpfung von Lebererkrankungen
RU2460534C1 (ru) * 2011-04-15 2012-09-10 Учреждение Российская академия наук Сибирское отделение (СО РАН) Институт общей и экспериментальной биологии (ИОЭБ СО РАН) Способ получения средства, обладающего анксиолитической активностью
CN103565959B (zh) * 2013-11-06 2015-04-08 李传平 一种治疗精神分裂症的汤剂
CN103961341B (zh) * 2014-05-30 2015-12-02 杨献华 一种治疗偏头痛的药物组合物及其应用
CN109071424B (zh) * 2016-02-29 2022-01-14 生物药品解决方案有限公司 氨基磺酸酯衍生物化合物、其制备方法及用途
KR102333460B1 (ko) * 2016-11-15 2021-12-15 경희대학교 산학협력단 쥐오줌풀 추출물을 유효성분으로 포함하는 측두엽 뇌전증 예방 또는 치료용 약학적 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617555C3 (de) * 1966-04-19 1974-09-19 Kali-Chemie Ag, 3000 Hannover Verfahren zur Isolierung von therapeutisch wertvollen Isovaleriansäureestern aus Valeriana- und Kentranthus-Extrakten
DE2230626B2 (de) * 1972-06-22 1978-07-20 Roland Dr. 7967 Bad Waldsee Schaette Baldrianpräparat
US5506268A (en) * 1993-06-11 1996-04-09 Nps Pharmaceuticals, Inc. Use of isovaleramide as a mild anxiolytic and sedative agent

Also Published As

Publication number Publication date
IL128724A0 (en) 2000-01-31
DK0938304T3 (da) 2005-03-14
CN1152677C (zh) 2004-06-09
AU4330297A (en) 1998-03-19
KR20000038194A (ko) 2000-07-05
AU728765B2 (en) 2001-01-18
HK1023725A1 (en) 2000-09-22
DE69731968D1 (de) 2005-01-20
CN1235541A (zh) 1999-11-17
ATE284683T1 (de) 2005-01-15
BR9713188A (pt) 1999-11-03
RU2232016C2 (ru) 2004-07-10
WO1998008498A1 (en) 1998-03-05
ES2235251T3 (es) 2005-07-01
PT938304E (pt) 2005-04-29
CN1531924A (zh) 2004-09-29
KR100594400B1 (ko) 2006-07-03
EP0938304B1 (en) 2004-12-15
CA2264577A1 (en) 1998-03-05
EP0938304A1 (en) 1999-09-01
JP2000504035A (ja) 2000-04-04
DE69731968T2 (de) 2005-12-22

Similar Documents

Publication Publication Date Title
IL128724A (en) Pharmaceutical compositions containing isovaleric acid derivatives for treating various neurological pathologies
WO2000051586A3 (en) Treating a variety of pathological conditions, including spasticity and convulsions, by effecting modulation of cns activity with isovaleramide, isovaleric acid, or a related compound
HUT64065A (en) Process for producing quinolone- and naphthyridonecarboxylic acid derivatives and pharmaceutical compositions comprising same as active ingredient
BG104679A (en) The use of fumaric acid derivatives in transplant medicine
MY118371A (en) Tetrahydrolipstatin containing compositions
CA2265766A1 (en) Rapidly disintegrating pellets
MY114889A (en) 1-phenyl-3-dimethylamino-propane derivatives having pharmacological activity
HUP0000558A3 (en) Use of active d vitamin analogues for producing pharmaceutical composition for the treatment of prostatic diseases
UA29450C2 (uk) Похідні гідроксамової кислоти, спосіб їх одержання, спосіб впливу на хвороби та фармацевтична або ветеринарна композиція, що їх містить
HUT60466A (en) Process for producing amino acid derivatives and pharmaceutical compositions comprising such active ingredient
HUT51254A (en) Process for producing amino acid derivatives and pharmaceutical compositions comprising same as active ingredient
EP0783299A4 (en) COMPOUNDS AND COMPOSITIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES
CA2289717A1 (en) Novel therapy for constipation
HUT58060A (en) Process for producing amino acid derivatives and pharmaceutical compositions comprising such active ingredient
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
WO1999044623A8 (en) Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a nsaid
HUT64082A (en) Process for producing steroid derivatives and pharmaceutical compositions comprising same as active ingredient
GB9212308D0 (en) Therapeutic compositions
MY120521A (en) Pharmaceutical microspheres of valproic acid for oral administration.
MY119090A (en) Synthetic polysaccharides, process for their preparation and pharmaceutical compositions containing them
HU9402292D0 (en) New baccatine-iii and 10-deacetyl-baccatine-iii derivatives, process for producing them and pharmaceutical compositions containing them as active component
IL105475A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS
IL105276A (en) (S)-a-PHENYL- 2-PYRIDINEETHANAMINE, ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
TW366284B (en) Pharmaceutical antitussive composition of delta-receptor antagonist
UA74388C2 (uk) Фармацевтичні композиції тизоксаніду і нітазоксаніду

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees